Name: Fabrazyme 35mg Powder for Infusion — Agalsidase Beta — Genzyme/Sanofi
Brand: Genzyme
Availability: InStock

Question 1

Where can I buy Fabrazyme (Agalsidase Beta) 35mg at the best price in 2026?

Accepted Answer

Pharmacy Remedy offers genuine Fabrazyme (Agalsidase Beta) 35mg by Genzyme/Sanofi at competitive wholesale prices — up to 40-60% lower than US retail pricing. We source directly from authorized European and Turkish distributors, ensuring 100% authenticity with batch-verifiable documentation and validated cold chain shipping. Contact us via WhatsApp for a personalized quote.

Question 2

What is Agalsidase Beta and what is Fabrazyme used for?

Accepted Answer

Agalsidase Beta is the active ingredient in Fabrazyme, an enzyme replacement therapy (ERT) developed by Genzyme (Sanofi). Fabrazyme is FDA-approved for the treatment of Fabry disease (alpha-galactosidase A deficiency), a rare X-linked lysosomal storage disorder. It provides the enzyme that patients with Fabry disease are missing or produce in insufficient quantities, helping to clear accumulated globotriaosylceramide (GL-3) from tissues.

Question 3

Is Agalsidase Beta the same as Fabrazyme?

Accepted Answer

Yes, Agalsidase Beta is the international nonproprietary name (INN) or generic name for Fabrazyme. Fabrazyme is the brand name marketed by Genzyme/Sanofi. Both refer to the exact same recombinant human alpha-galactosidase A enzyme produced in Chinese Hamster Ovary (CHO) cells. When you search for 'buy agalsidase beta' or 'buy Fabrazyme', you're looking for the same medication.

Question 4

How does Agalsidase Beta (Fabrazyme) work for Fabry disease?

Accepted Answer

Fabrazyme works through enzyme replacement therapy (ERT). In Fabry disease, patients lack sufficient alpha-galactosidase A enzyme, causing accumulation of glycosphingolipids (primarily GL-3/Gb3) in lysosomes of cells throughout the body. Agalsidase Beta provides an exogenous source of this missing enzyme, which is taken up by cells via mannose-6-phosphate receptors, localizes to lysosomes, and catalyzes the hydrolysis of GL-3, reducing its accumulation in kidneys, heart, and other organs.

Question 5

What is the recommended dosage for Fabrazyme (Agalsidase Beta)?

Accepted Answer

The recommended dosage of Fabrazyme is 1 mg/kg body weight administered as an intravenous infusion every 2 weeks. The initial infusion rate should be no more than 0.25 mg/min (15 mg/hr). The rate may be increased gradually if the infusion is well tolerated. Each 35mg vial is reconstituted with Sterile Water for Injection and then diluted in 0.9% sodium chloride solution for infusion. Premedication with antipyretics and/or antihistamines may be recommended.

Question 6

What are the common side effects of Agalsidase Beta (Fabrazyme)?

Accepted Answer

The most common adverse reactions (≥10%) include infusion-associated reactions (IAR): rigors, pyrexia, feeling cold, nausea, vomiting, headache, paresthesia, fatigue, pruritus, pain in extremity, and nasal congestion. Serious IARs including anaphylaxis can occur. Patients may develop IgG antibodies to agalsidase beta, which can affect treatment efficacy. Fabrazyme carries warnings for infusion reactions and the development of anti-drug antibodies.

Question 7

Can Fabrazyme be shipped to the UAE, Saudi Arabia, and Middle East?

Accepted Answer

Yes, we provide worldwide shipping of genuine Genzyme/Sanofi Fabrazyme (Agalsidase Beta) 35mg to UAE, Saudi Arabia, Kuwait, Qatar, Bahrain, Oman, Iraq, Jordan, and all Middle Eastern countries. Fabrazyme requires validated cold chain shipping (2-8°C) and is shipped in temperature-monitored packaging. Delivery takes 3-5 business days with full documentation.

Question 8

What clinical evidence supports Fabrazyme's efficacy?

Accepted Answer

Key clinical data includes: Phase 3 pivotal trial demonstrating significant clearance of GL-3 from capillary endothelium of kidney, heart, and skin. Long-term extension studies showing sustained stabilization of renal function (eGFR) over 10+ years of treatment. Studies showing reduction in cardiac mass (left ventricular hypertrophy) and improvement in cardiac function. The pivotal study showed GL-3 clearance from kidney capillary endothelium in 69% of patients vs 0% placebo at 20 weeks.

Question 9

Is Fabrazyme available as a generic (generic agalsidase beta)?

Accepted Answer

As of 2026, there is no generic version of Fabrazyme (agalsidase beta). As a complex recombinant biologic produced in CHO cells, it cannot be easily replicated. There is an alternative ERT — Replagal (agalsidase alfa by Takeda) — which is a different molecule at a different dose (0.2 mg/kg vs 1 mg/kg). No biosimilar agalsidase beta is currently available. Pharmacy Remedy supplies only authentic Genzyme/Sanofi Fabrazyme.

Question 10

Can hospitals get wholesale pricing for Fabrazyme (Agalsidase Beta)?

Accepted Answer

Yes, we offer institutional and wholesale pricing for hospitals, metabolic disease centers, and specialty pharmacies. Volume discounts are available for regular orders, with NET 30 payment terms for qualified institutional buyers. Fabrazyme 35mg is supplied as a lyophilized powder in single-use vials.

Question 11

Why is Fabrazyme so expensive and how can I save money?

Accepted Answer

Fabrazyme costs approximately $15,000-20,000 per vial (35mg) in the US, with annual treatment costs exceeding $200,000-300,000 depending on patient weight. As an orphan drug for a rare disease with complex biomanufacturing, pricing reflects development costs and small patient population. Through Pharmacy Remedy, hospitals can save 40-60% compared to US retail by sourcing from authorized Turkish and European distributors.

Question 12

What is the difference between Fabrazyme and Replagal?

Accepted Answer

Both are enzyme replacement therapies for Fabry disease but differ significantly. Fabrazyme (agalsidase beta, Genzyme/Sanofi) is dosed at 1 mg/kg every 2 weeks and is produced in CHO cells. Replagal (agalsidase alfa, Takeda) is dosed at 0.2 mg/kg every 2 weeks and produced in a human cell line. Fabrazyme has more robust Phase 3 clinical trial data and is the only ERT approved in the US for Fabry disease. Studies suggest comparable efficacy on renal and cardiac outcomes.

Question 13

How should Fabrazyme be stored and handled?

Accepted Answer

Fabrazyme lyophilized powder must be stored at 2-8°C (36-46°F). Do not freeze. Protect from light. After reconstitution, the solution should be diluted immediately and the infusion should begin within 24 hours. Pharmacy Remedy ships all Fabrazyme orders in validated cold chain packaging with temperature monitors and data loggers.

Question 14

Where to buy Agalsidase Beta cheapest worldwide?

Accepted Answer

Pharmacy Remedy offers the most competitive worldwide pricing for genuine Genzyme/Sanofi Fabrazyme (Agalsidase Beta) 35mg. Our prices are 40-60% below US retail and 25-35% below most European markets. We source from authorized distributors with full cold chain integrity. Contact us via WhatsApp for current pricing — we serve hospitals in over 40 countries.

Question 15

Is a prescription required to buy Fabrazyme?

Accepted Answer

Yes, Fabrazyme (Agalsidase Beta) is a prescription-only orphan medication that must be administered in a clinical setting with monitoring capabilities for infusion-associated reactions. We supply to licensed hospitals, metabolic disease centers, and authorized pharmacies only. A valid prescription or medical order is required.

Source	Price (per vial)	Savings
US Retail Pharmacy	$15,000 - $20,000	—
European Market	$10,000 - $14,000	~30%
Pharmacy Remedy ✓	Contact for Quote	40-60% Savings

Feature	Fabrazyme (Agalsidase Beta)	Replagal (Agalsidase Alfa)
Active Ingredient	Agalsidase Beta	Agalsidase Alfa
Manufacturer	Genzyme/Sanofi	Takeda (Shire)
Dose	1 mg/kg every 2 weeks	0.2 mg/kg every 2 weeks
Production System	CHO cells	Human cell line
FDA Approved	Yes (2003)	No (EU only)
Phase 3 Data	Robust — GL-3 clearance	Smaller trials
Available via Pharmacy Remedy	✓ Yes — Best Price	Contact for availability

Buy Fabrazyme (Agalsidase Beta) 35mg Online
Best Wholesale Price 2026 — Genuine Genzyme Product

FABRAZYME® 35mg Powder for Infusion

What is Agalsidase Beta (Fabrazyme)? — Mechanism of Action

Why Buy Fabrazyme (Agalsidase Beta) From Pharmacy Remedy?

40-60% Below US Retail

100% Authentic Genzyme Product

Validated Cold Chain (2-8°C)

Licensed Pharmaceutical Supplier

Full Documentation

Dedicated Rare Disease Support

Fabrazyme (Agalsidase Beta) Price Comparison 2026

Fabrazyme vs Replagal — ERT Comparison for Fabry Disease

Fabrazyme (Agalsidase Beta) FAQ — Frequently Asked Questions

Ready to Order Fabrazyme (Agalsidase Beta) 35mg?

Licensed Supplier

100% Original

Worldwide Delivery

24/7 Support

Buy Fabrazyme (Agalsidase Beta) 35mg OnlineBest Wholesale Price 2026 — Genuine Genzyme Product